Skip to main content
Premium Trial:

Request an Annual Quote

Wall Street Rewards Caliper Life Sciences on 22-Percent Q3 Revenue Growth

This article has been updated to include stock price.

NEW YORK, Nov. 5 (GenomeWeb News) - Shares in Caliper Life Sciences were up 4 percent to $7.02 in mid-afternoon trade after the company reported a 22-percent jump in third-quarter revenue and narrowed net losses.


Caliper said that increased interest from pharmaceutical companies in its microfluidic screening platform helped drive revenue in the period to $20.2 million from $16.5 million year over year.


The company said that during the last three months, Merck, Johnson & Johnson, and Taisho Pharmaceutical of Japanhad each purchased a LabChip 3,000 microfluidic screening system for the first time. In addition, Aventis and Pfizer recently bought additional systems, according to the company.


Caliper spent $5.3 million on R&D during the quarter, down from $8.8 million a year ago.


The company's net loss was cut in half, to $5.1 million, or $.17 per share, compared to $10.1 million, or $.37 per share, during the third quarter of 2003.


As of Sept. 30, Caliper had $6.1 million in cash and cash equivalents and $43.1 million in short-term marketable securities.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.